ketamine
DrugBefore skin incision, a bolus 0.35 mg/kg ketamine will be given followed by a continuous infusion 0.25 mg/kg/hr.
Ketamine infusion will be stopped 30 minutes before the end of the surgery
NCT Number: NCT07197684
The goal of this clinical trial is to is to compare the effectiveness of ultrasound-guided Pecs block with intravenous ketamine versus intravenous ketamine infusion alone in preventing Chronic Post-Surgical Pain (CPSP) in patients undergoing breast cancer surgery. The main question it aims to answer is,
How effective is the ketamine and ketamine with pecs block in reducing the frequency of Chronic Post-Surgical Pain after breast cancer surgery
Trial opening soon.
Get Notified18 year–75 year
Female
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Before skin incision, a bolus 0.35 mg/kg ketamine will be given followed by a continuous infusion 0.25 mg/kg/hr.
Ketamine infusion will be stopped 30 minutes before the end of the surgery
Pecs block will be performed before surgical incision with the help of an ultrasound (US) by experienced anesthesiologist. The drug used for the pecs block will be two syringes of 10ml and 20 ml containing bupivacaine 0.25% (total 30 ml).
Intravenous Nalbuphine 0.1 mg/kg
Intravenous Paracetamol 1g or 15mg/kg (if weight is < 50kg).
Time frame: Data will be collected from patients in the breast clinic or via telephone at one week, 1,2, 3, and 6 months after surgery.
Pain intensity will be assessed using an 11-point numeric rating scale (NRS) by an investigator blinded to group allocation. Scores range from 0 (no pain) to 10 (worst imaginable pain), with higher scores indicating greater pain severity and therefore a worse outcome.
Data will be collected from patients in the breast clinic or via telephone at one week, 1,2, 3, and 6 months after surgery.
All patients will be followed till six months after discharge from the hospital.
Time frame: Till six months after discharge from the hospital.
Patients will be asked to describe the character(quality) of their pain (e.g., burning, sharp, pricking, electric-shock-like) during follow-up visits.
patients will be subjectively asked to describe the quality of pain.
Time frame: Till six months after discharge from the hospital.
From three months to six months.
Time frame: Till six months after discharge from the hospital.
Patients will be asked to report the location of any persistent pain during follow-up visits. Using a standardized body map diagram, they will indicate whether pain is present at the surgical site or in surrounding areas (e.g., axilla, upper arm, upper back, chest wall).
Contact information is provided by the study sponsor or research team.
Aga Khan University
Other
Effect of Ultrasound Guided Pecs Block With Intravenous Ketamine and Ketamine Infusion Alone For Prevention of Chronic Post-Surgical Pain in Patients Undergoing Breast Cancer Surgery: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04874038
Breast Cancer, Breast Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT06404983
Anesthesia, Breast Cancer
Ioannina, Epirus, Greece
View Trial DetailsNCT05146778
Breast Cancer, Breast Diseases
Seoul, South Korea
View Trial DetailsNCT03912948
Breast Cancer, Breast Diseases
Toulouse, Occitanie, France
View Trial Details